BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30318154)

  • 1. 25 years after the `Rio Convention'--Lessons learned in the context of sustainable development and protecting indigenous and local knowledge.
    Heinrich M; Hesketh A
    Phytomedicine; 2019 Feb; 53():332-343. PubMed ID: 30318154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access and benefit sharing--The perspective of basic research.
    Beck E
    Phytomedicine; 2019 Feb; 53():302-307. PubMed ID: 30503101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access and Benefit Sharing Under the Nagoya Protocol-
    Heinrich M; Scotti F; Andrade-Cetto A; Berger-Gonzalez M; Echeverría J; Friso F; Garcia-Cardona F; Hesketh A; Hitziger M; Maake C; Politi M; Spadafora C; Spadafora R
    Front Pharmacol; 2020; 11():765. PubMed ID: 32581783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnobotany and intellectual property rights.
    Barton JH
    Ciba Found Symp; 1994; 185():214-21; discussion 221-7. PubMed ID: 7736856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intellectual property rights and traditional medicine: policy dilemmas at the interface.
    Timmermans K
    Soc Sci Med; 2003 Aug; 57(4):745-56. PubMed ID: 12821021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sharing the benefits of biodiversity: a new international protocol and its implications for research and development.
    Oliva MJ
    Planta Med; 2011 Jul; 77(11):1221-7. PubMed ID: 21674434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who Are Indigenous and Local Communities and What Is Traditional Knowledge for Virus Access and Benefit-sharing? A Textual Analysis of the Convention on Biological Diversity and Its Nagoya Protocol.
    Rourke MF
    J Law Med; 2018 Apr; 25(3):707-726. PubMed ID: 29978663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological diversity in the patent system.
    Oldham P; Hall S; Forero O
    PLoS One; 2013; 8(11):e78737. PubMed ID: 24265714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rooibos Benefit Sharing Agreement-Breaking New Ground with Respect, Honesty, Fairness, and Care.
    Schroeder D; Chennells R; Louw C; Snyders L; Hodges T
    Camb Q Healthc Ethics; 2020 Apr; 29(2):285-301. PubMed ID: 31685054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Including Digital Sequence Data in the Nagoya Protocol Can Promote Data Sharing.
    Ambler J; Diallo AA; Dearden PK; Wilcox P; Hudson M; Tiffin N
    Trends Biotechnol; 2021 Feb; 39(2):116-125. PubMed ID: 32654776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A perspective on natural products research and ethnopharmacology in Mexico: the eagle and the serpent on the prickly pear cactus.
    Heinrich M; Frei Haller B; Leonti M
    J Nat Prod; 2014 Mar; 77(3):678-89. PubMed ID: 24559070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of the Nagoya Protocol in the European Union and in Germany.
    Greiber T
    Phytomedicine; 2019 Feb; 53():313-318. PubMed ID: 30392747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POLITICS OF BIOPIRACY: AN ADVENTURE INTO HOODIA/XHOBA PATENTING IN SOUTHERN AFRICA.
    Amusan L
    Afr J Tradit Complement Altern Med; 2017; 14(1):103-109. PubMed ID: 28480387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sharing the benefits of genetic resources: from biodiversity to human genetics.
    Schroeder D; Lasén-Díaz C
    Dev World Bioeth; 2006 Dec; 6(3):135-43. PubMed ID: 17038005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopiracy of natural products and good bioprospecting practice.
    Efferth T; Banerjee M; Paul NW; Abdelfatah S; Arend J; Elhassan G; Hamdoun S; Hamm R; Hong C; Kadioglu O; Naß J; Ochwangi D; Ooko E; Ozenver N; Saeed ME; Schneider M; Seo EJ; Wu CF; Yan G; Zeino M; Zhao Q; Abu-Darwish MS; Andersch K; Alexie G; Bessarab D; Bhakta-Guha D; Bolzani V; Dapat E; Donenko FV; Efferth M; Greten HJ; Gunatilaka L; Hussein AA; Karadeniz A; Khalid HE; Kuete V; Lee IS; Liu L; Midiwo J; Mora R; Nakagawa H; Ngassapa O; Noysang C; Omosa LK; Roland FH; Shahat AA; Saab A; Saeed EM; Shan L; Titinchi SJ
    Phytomedicine; 2016 Feb; 23(2):166-73. PubMed ID: 26926178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopiracy versus One-World Medicine-From colonial relicts to global collaborative concepts.
    Efferth T; Banerjee M; Abu-Darwish MS; Abdelfatah S; Böckers M; Bhakta-Guha D; Bolzani V; Daak S; Demirezer ÖL; Dawood M; Efferth M; El-Seedi HR; Fischer N; Greten HJ; Hamdoun S; Hong C; Horneber M; Kadioglu O; Khalid HE; Khalid SA; Kuete V; Mahmoud N; Marin J; Mbaveng A; Midiwo J; Nakagawa H; Naß J; Ngassapa O; Ochwang'i D; Omosa LK; Ooko EA; Özenver N; Poornima P; Romero MR; Saeed MEM; Salgueiro L; Seo EJ; Yan G; Yasin Z; Saeed EM; Paul NW
    Phytomedicine; 2019 Feb; 53():319-331. PubMed ID: 30190231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intellectual property rights in Costa Rica in the light of the Biodiversity Convention].
    Salazar R; Cabrera JA
    J Ethnopharmacol; 1996 Apr; 51(1-3):177-93. PubMed ID: 9213615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of Nagoya Protocol on traditional Chinese medicine].
    Yang G; Xu J; Chi XL; Zang CX; Que L
    Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(2):396-400. PubMed ID: 29552861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juridical and sociocultural problems on the definition of a law concerning property, usage and access to genetic resources in Colombia.
    Calle R
    J Ethnopharmacol; 1996 Apr; 51(1-3):127-42; discussion 142-6. PubMed ID: 9213609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of Nagoya Protocol on access and benefit-sharing in Peru: Implications for researchers.
    Friso F; Mendive F; Soffiato M; Bombardelli V; Hesketh A; Heinrich M; Menghini L; Politi M
    J Ethnopharmacol; 2020 Sep; 259():112885. PubMed ID: 32311487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.